Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pihlajalinna OyjFRA:38P +1.33%71 Debt-to-Equity is 1.13 as of Jun. 2026, which is 28% below its 10-year median of 1.57. GuruFocus rates FRA:38P with a GF Score™ of 71/100 and a GF Value™ of €9.54 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 558 Healthcare Providers & Services companies, Pihlajalinna Oyj ranks worse than 76.52% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Pihlajalinna Oyj's Debt-to-Equity or its related term are showing as below:
FRA:38P'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.5 Med: 1.57 Max: 3.23
Current: 1.13
During the past 13 years, the highest Debt-to-Equity Ratio of Pihlajalinna Oyj was 3.23. The lowest was 0.50. And the median was 1.57.
FRA:38P's Debt-to-Equity is ranked worse than 76.52% of 558
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs FRA:38P: 1.13
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Pihlajalinna Oyj Debt-to-Equity Related Terms
Pihlajalinna Oyj Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Pihlajalinna Oyj's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:38P vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Pihlajalinna Oyj's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pihlajalinna Oyj Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pihlajalinna Oyj's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Pihlajalinna Oyj's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pihlajalinna Oyj (FRA:38P) has a Debt-to-Equity of 1.13 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Pihlajalinna Oyj and its competitors. This is 28% below median its historical median of 1.57. Over the past decade, Pihlajalinna Oyj's Debt-to-Equity has ranged from 0.50 to 3.23. According to the industry distribution chart, Pihlajalinna Oyj ranks #427 out of 558 companies in the Healthcare Providers & Services industry, placing it in the top 76.5%.
Is Pihlajalinna Oyj's Debt-to-Equity too high?
Pihlajalinna Oyj's current Debt-to-Equity of 1.13 is 28% below median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 3.23. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Pihlajalinna Oyj's value of 1.13 is 169% above this industry median. Based on the distribution chart, Pihlajalinna Oyj ranks #427 out of 558 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pihlajalinna Oyj has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pihlajalinna Oyj's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Pihlajalinna Oyj ranks #427 out of 558 companies for Debt-to-Equity. This places Pihlajalinna Oyj in the lower half of its industry. The industry median Debt-to-Equity is 0.42. Pihlajalinna Oyj's value of 1.13 is 169% above this benchmark. Historically, Pihlajalinna Oyj's own Debt-to-Equity has ranged from 0.50 to 3.23 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 0.42, Pihlajalinna Oyj has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 558 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pihlajalinna Oyj's current Debt-to-Equity of 1.13 is 169% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Pihlajalinna Oyj and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pihlajalinna Oyj's current Debt-to-Equity is 1.13, which is 28% below median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pihlajalinna Oyj stock overvalued right now?
Based on GuruFocus' analysis, Pihlajalinna Oyj (FRA:38P) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.54, compared to a current price of €10.66 — trading 11.7% above its estimated fair value. The current Debt-to-Equity is 1.13, which is 28% below median its 10-year median of 1.57 and 169% above the Healthcare Providers & Services industry median of 0.42. Pihlajalinna Oyj's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Pihlajalinna Oyj (FRA:38P), the current Debt-to-Equity is 1.13 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pihlajalinna Oyj (FRA:38P) Overvalued in 2026?
Based on GuruFocus' analysis, Pihlajalinna Oyj stock appears to be overvalued.
The current stock price of €10.66 is trading 11.7% above its estimated GF Value™ of €9.54.
GuruFocus considers Pihlajalinna Oyj to be Modestly Overvalued.
Key valuation signals for FRA:38P:
Debt-to-Equity: 1.13 (28% below median its 10-year median of 1.57)
GF Value™: €9.54 vs. price of €10.66 (11.7% above fair value)
Industry Position: 169% above the Healthcare Providers & Services median (#427 of 558)
No single metric tells the full story. See the FRA:38P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pihlajalinna Oyj is a private social and healthcare service providers in Finland. It provides comprehensive, high-quality services through private clinics, hospitals, remote channels, occupational healthcare, and tailored social and healthcare solutions for the public sector. It has two reportable segments: Private Healthcare Services and Public Services. The Private Healthcare Services operating segment consists of private clinic, diagnostics, hospital, occupational healthcare, remote and fitness center services. The Public Services operating segment consists of social and healthcare services produced for the public sector, which include outsourcing and housing services, mainly remotely produced responsible doctor services, as well as a wide range of staffing and recruitment services.
71GF Score
Get the complete analysis for FRA:38P
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:38P has been successfully added to your 
